6-32843852-G-T

Variant summary

Our verdict is Benign. The variant received -15 ACMG points: 1P and 16B. PP3BP6_Very_StrongBA1

The NM_148919.4(PSMB8):​c.145C>A​(p.Gln49Lys) variant causes a missense, splice region change. The variant allele was found at a frequency of 0.133 in 1,612,468 control chromosomes in the GnomAD database, including 14,765 homozygotes. In-silico tool predicts a benign outcome for this variant. 2/3 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.13 ( 1306 hom., cov: 31)
Exomes 𝑓: 0.13 ( 13459 hom. )

Consequence

PSMB8
NM_148919.4 missense, splice_region

Scores

4
13
Splicing: ADA: 0.9937
2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:6

Conservation

PhyloP100: 4.24

Publications

107 publications found
Variant links:
Genes affected
PSMB8 (HGNC:9545): (proteasome 20S subunit beta 8) The proteasome is a multicatalytic proteinase complex with a highly ordered ring-shaped 20S core structure. The core structure is composed of 4 rings of 28 non-identical subunits; 2 rings are composed of 7 alpha subunits and 2 rings are composed of 7 beta subunits. Proteasomes are distributed throughout eukaryotic cells at a high concentration and cleave peptides in an ATP/ubiquitin-dependent process in a non-lysosomal pathway. An essential function of a modified proteasome, the immunoproteasome, is the processing of class I MHC peptides. This gene encodes a member of the proteasome B-type family, also known as the T1B family, that is a 20S core beta subunit. This gene is located in the class II region of the MHC (major histocompatibility complex). Expression of this gene is induced by gamma interferon and this gene product replaces catalytic subunit 3 (proteasome beta 5 subunit) in the immunoproteasome. Proteolytic processing is required to generate a mature subunit. Two alternative transcripts encoding two isoforms have been identified; both isoforms are processed to yield the same mature subunit. [provided by RefSeq, Jul 2008]
PSMB8-AS1 (HGNC:39758): (PSMB8 antisense RNA 1 (head to head))

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -15 ACMG points.

PP3
Splicing predictors support a deleterious effect. Scorers claiming Pathogenic: dbscSNV1_ADA, dbscSNV1_RF. No scorers claiming Uncertain. Scorers claiming Benign: max_spliceai.
BP6
Variant 6-32843852-G-T is Benign according to our data. Variant chr6-32843852-G-T is described in ClinVar as Benign. ClinVar VariationId is 356368.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.173 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
PSMB8NM_148919.4 linkc.145C>A p.Gln49Lys missense_variant, splice_region_variant Exon 1 of 6 ENST00000374882.8 NP_683720.2 P28062-1X5CMJ9

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
PSMB8ENST00000374882.8 linkc.145C>A p.Gln49Lys missense_variant, splice_region_variant Exon 1 of 6 1 NM_148919.4 ENSP00000364016.4 P28062-1

Frequencies

GnomAD3 genomes
AF:
0.128
AC:
19469
AN:
151988
Hom.:
1307
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.111
Gnomad AMI
AF:
0.174
Gnomad AMR
AF:
0.152
Gnomad ASJ
AF:
0.0835
Gnomad EAS
AF:
0.183
Gnomad SAS
AF:
0.178
Gnomad FIN
AF:
0.123
Gnomad MID
AF:
0.104
Gnomad NFE
AF:
0.129
Gnomad OTH
AF:
0.114
GnomAD2 exomes
AF:
0.144
AC:
35259
AN:
245218
AF XY:
0.144
show subpopulations
Gnomad AFR exome
AF:
0.110
Gnomad AMR exome
AF:
0.195
Gnomad ASJ exome
AF:
0.0885
Gnomad EAS exome
AF:
0.180
Gnomad FIN exome
AF:
0.123
Gnomad NFE exome
AF:
0.134
Gnomad OTH exome
AF:
0.131
GnomAD4 exome
AF:
0.133
AC:
194496
AN:
1460362
Hom.:
13459
Cov.:
32
AF XY:
0.133
AC XY:
96872
AN XY:
726508
show subpopulations
African (AFR)
AF:
0.109
AC:
3656
AN:
33480
American (AMR)
AF:
0.191
AC:
8554
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.0883
AC:
2308
AN:
26136
East Asian (EAS)
AF:
0.161
AC:
6393
AN:
39700
South Asian (SAS)
AF:
0.154
AC:
13306
AN:
86254
European-Finnish (FIN)
AF:
0.124
AC:
6473
AN:
52024
Middle Eastern (MID)
AF:
0.111
AC:
640
AN:
5756
European-Non Finnish (NFE)
AF:
0.131
AC:
145375
AN:
1111912
Other (OTH)
AF:
0.129
AC:
7791
AN:
60376
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.479
Heterozygous variant carriers
0
9586
19172
28757
38343
47929
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
5370
10740
16110
21480
26850
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.128
AC:
19468
AN:
152106
Hom.:
1306
Cov.:
31
AF XY:
0.129
AC XY:
9566
AN XY:
74332
show subpopulations
African (AFR)
AF:
0.110
AC:
4580
AN:
41476
American (AMR)
AF:
0.151
AC:
2315
AN:
15296
Ashkenazi Jewish (ASJ)
AF:
0.0835
AC:
290
AN:
3472
East Asian (EAS)
AF:
0.183
AC:
944
AN:
5158
South Asian (SAS)
AF:
0.178
AC:
856
AN:
4822
European-Finnish (FIN)
AF:
0.123
AC:
1301
AN:
10588
Middle Eastern (MID)
AF:
0.109
AC:
32
AN:
294
European-Non Finnish (NFE)
AF:
0.129
AC:
8755
AN:
67978
Other (OTH)
AF:
0.112
AC:
236
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.498
Heterozygous variant carriers
0
864
1728
2591
3455
4319
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
226
452
678
904
1130
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.130
Hom.:
6142
Bravo
AF:
0.129
TwinsUK
AF:
0.128
AC:
473
ALSPAC
AF:
0.114
AC:
439
ESP6500AA
AF:
0.116
AC:
349
ESP6500EA
AF:
0.133
AC:
723
ExAC
AF:
0.144
AC:
16858
Asia WGS
AF:
0.123
AC:
428
AN:
3478
EpiCase
AF:
0.129
EpiControl
AF:
0.134

ClinVar

Significance: Benign
Submissions summary: Benign:6
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:2
Mar 29, 2016
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: Frequency -

Nov 14, 2023
Unidad de Genómica Garrahan, Hospital de Pediatría Garrahan
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is classified as Benign based on local population frequency. This variant was detected in 23% of patients studied by a panel of primary immunodeficiencies. Number of patients: 22. Only high quality variants are reported. -

not provided Benign:1
Nov 12, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is associated with the following publications: (PMID: 11669176, 21303409, 17366619, 22037870) -

Proteasome-associated autoinflammatory syndrome 1 Benign:1
Mar 06, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Proteosome-associated autoinflammatory syndrome Benign:1
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Autoinflammatory syndrome Benign:1
Jan 14, 2022
Genome Diagnostics Laboratory, The Hospital for Sick Children
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.11
BayesDel_addAF
Benign
-0.53
T
BayesDel_noAF
Benign
-0.40
CADD
Uncertain
25
DANN
Uncertain
0.98
DEOGEN2
Benign
0.019
T;T
Eigen
Benign
0.17
Eigen_PC
Uncertain
0.31
FATHMM_MKL
Benign
0.70
D
MetaRNN
Benign
0.0016
T;T
MetaSVM
Benign
-1.1
T
MutationAssessor
Uncertain
2.6
.;M
PhyloP100
4.2
PrimateAI
Uncertain
0.60
T
PROVEAN
Benign
-1.0
N;N
REVEL
Benign
0.070
Sift
Benign
0.21
T;T
Sift4G
Benign
0.22
T;T
Polyphen
0.0
.;B
Vest4
0.21
MPC
0.71
ClinPred
0.017
T
GERP RS
5.6
PromoterAI
-0.021
Neutral
Varity_R
0.18
gMVP
0.61
Mutation Taster
=95/5
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Pathogenic
0.99
dbscSNV1_RF
Pathogenic
0.87
SpliceAI score (max)
0.060
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2071543; hg19: chr6-32811629; COSMIC: COSV62754653; COSMIC: COSV62754653; API